Analysts expect Parabilis Medicines, Inc. to report revenue of 313,015.20 for Q3 26, against a range of 283,788.66 to 342,241.74. The most recent reported quarter, Q2 26, came in at 100,000.00, a 99.4% miss against the 17.12 M consensus.
| Metric | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 100,000.00 | - | - | - | - |
| High Estimate | - | 18.15 M | 342,241.74 | 750,339.69 | 2.06 M | 2.78 M |
| Low Estimate | - | 16.10 M | 283,788.66 | 665,280.73 | 1.75 M | 2.35 M |
| Consensus Estimate | - | 17.12 M | 313,015.20 | 707,810.21 | 1.91 M | 2.56 M |
Analysts expect Parabilis Medicines, Inc. to report earnings per share of -0.34 for Q3 26, against a range of -0.36 to -0.32. The most recent reported quarter, Q2 26, came in at -2.32 , in line with the -0.17 consensus.
| Metric | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|
| Reported (Actual) | -0.72 | -2.32 | - | - | - | - |
| High Estimate | - | -0.15 | -0.32 | -0.34 | -0.33 | -0.31 |
| Low Estimate | - | -0.19 | -0.36 | -0.40 | -0.35 | -0.35 |
| Consensus Estimate | - | -0.17 | -0.34 | -0.37 | -0.34 | -0.33 |
Pull Wall Street consensus for Parabilis Medicines, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PBLS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PBLS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PBLS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();